Research

Thesis

Dr. Gehlbach’s thesis and Ph.D. work focused on the basic mechanisms of microvascular ischemia and reperfusion and its effects on neural tissue. This led then led to research on pathological angiogenesis in retinal disease

During the last 10 years Dr. Gelhbach’s research has focused on inventing and developing technology that surpasses human capabilities to perform retinal microsurgery on the single macron scale.

Research Program Building and Leadership

Has served as the Inaugural Director for the Wilmer Gene Therapy Vector Core.

Has performed foundational work addressing retinal disease. Such research includes: work on ischemia and reperfusion injury in the retinal microvasculature; work on pathological angiogenesis in animal models of retinal disease; work on gene therapy for retinal disease and the development of novel techniques for surgical intervention..

Research Demonstration Activities

Prior research demonstrations provided, include but are not limited to: Alcon, QLT, Sclera Inc., GenVec Inc., Auris Surgical Robots, Marriott Foundation, Zeiss, Lutronics, Carnegie Mellon University, Coulter Foundation, Charles Rivers Laboratories, National Institutes of Health and a number of Donors/Friends of the Wilmer, Whiting and Whitaker Institutes, Johns Hopkins University, and others.